1. Home
  2. TALK vs GHRS Comparison

TALK vs GHRS Comparison

Compare TALK & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Talkspace Inc.

TALK

Talkspace Inc.

HOLD

Current Price

$5.23

Market Cap

872.7M

Sector

Health Care

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$26.51

Market Cap

947.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TALK
GHRS
Founded
2012
2018
Country
United States
Ireland
Employees
598
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
872.7M
947.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TALK
GHRS
Price
$5.23
$26.51
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$6.42
$41.38
AVG Volume (30 Days)
2.7M
242.2K
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.02
N/A
Revenue Next Year
$21.24
N/A
P/E Ratio
$155.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$11.32
52 Week High
$5.24
$28.96

Technical Indicators

Market Signals
Indicator
TALK
GHRS
Relative Strength Index (RSI) 56.56 61.07
Support Level $5.19 $12.88
Resistance Level $5.23 $28.96
Average True Range (ATR) 0.02 1.69
MACD 0.00 0.09
Stochastic Oscillator 72.73 71.44

Price Performance

Historical Comparison
TALK
GHRS

About TALK Talkspace Inc.

Talkspace Inc is a virtual behavioral healthcare company offering its members convenient and affordable access to a fully-credentialed network of qualified providers across a wide and growing spectrum of care through virtual psychotherapy and psychiatry. It is a single destination for comprehensive mental health care, including therapy for individuals, couples, and teens, as well as psychiatric treatment and medication management (18+), and self-guided tools and resources. The company's customers include Health insurance plans from commercial and government institutions, and employee assistance programs, Direct-to-Enterprise, and Individual subscribers. The company operates as a single segment.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: